Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (553)	5/18/2000 10:42:00 AM
From: RWReeves	Read Replies (1) \| Respond to of 743

Company with an interesting platform, and making money? In BT? I have followed their antics for 7 years. I always hoped they would get it together and use their nice technology for rapid screening and biotech R&D including genomics. The same bunch that started this outfit are now at CALP and ACLA. See the potential now? Anyway, finally making decent sales and earnings. ABAX. Look before you leap, but worth the look. D:Yes I have some, not a lot. BTW VVUS today doing well. Now up nearly 40% off the lows. RWR

To: RWReeves who wrote (553)	5/31/2000 9:18:00 AM
From: Toni Wheeler	Read Replies (2) \| Respond to of 743

RWR... Not under a buck, but lonely, UNloved and UNnoticed lately....GNLB: Genelabs Submits Clinical Sections of New Drug Application to FDA For Lupus Treatment - GL701 Has Potential to Be First New Lupus Therapy in 40 Years - www2.marketwatch.com. My best, T.